Modelling clinical decay data using exponential functions

Springer Proceedings in Physics

Volumn 3, Issue , 2011, Pages 183-203

  Cox, Maurice G ^a  

^a NATIONAL PHYSICAL LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APPROXIMATION ALGORITHMS; DRUG DOSAGE; ENZYME ACTIVITY; UNCERTAINTY ANALYSIS; EXPONENTIAL FUNCTIONS;

ABSORBED DOSE; BIOLOGICAL PROCESS; CANCER PATIENTS; CLINICAL DATA; DECAY FUNCTION; DRUG ADMINISTRATION; MEASUREMENT UNCERTAINTY; TIME SEQUENCES;

EXPONENTIAL FUNCTIONS; DRUG DOSAGE;

EID: 84904036070     PISSN: 09308989     EISSN: 18674941     Source Type: Conference Proceeding    
DOI: 10.1007/978-3-642-16876-5_8     Document Type: Conference Paper

References (14)

1. BIPM, IEC, IFCC, ILAC, ISO, IUPAC, IUPAP, and OIML. Evaluation of measurement data -guide to the expression of uncertainty in measurement. Joint Committee for Guides in Metrology, JCGM 100:2008. www.bipm.org/utils/common/ documents/jcgm/JCGM 100 2008 E.pdf.
2. BIPM, IEC, IFCC, ILAC, ISO, IUPAC, IUPAP, and OIML. Evaluation of measurement data -supplement 1 to the "Guide to the expression of uncertainty in measurement" -propagation of distributions using a Monte Carlo method. Joint Committee for Guides in Metrology, JCGM 101:2008. www.bipm.org/utils/common/documents/jcgm/JCGM 101 2008 E.pdf.
3. M.G. Cox: The evaluation of key comparison data. Metrologia 39, 2002, 589-595.
4. M.G. Cox and P.M. Harris: SSfM Best Practice Guide No. 6, Uncertainty Evaluation. Technical Report DEM-ES-011, National Physical Laboratory, Teddington, UK, 2006. http://publications.npl.co.uk/npl web/pdf/dem es11.pdf.
5. A. Divoli, A. Spinelli, S. Chittenden, D. Dearnaley, and G. Flux: Whole-body dosimetry for targeted radionuclide therapy using spectral analysis. Cancer Biol. Radiopharm. 20, 2005, 66-71.
6. C. Elster: Calculation of uncertainty in the presence of prior knowledge. Metrologia 44, 2007, 111-116.
7. G.D. Flux, M.J. Guy, R. Beddows, M. Pryor, and M.A. Flower: Estimation and implications of random errors in whole-body dosimetry for targeted radionuclide therapy. Phys. Med. Biol. 47, 2002, 3211-3223.
8. R. Francis and R.H.J. Begent: Monoclonal antibody targeting therapy: an overview. In Targeted Therapy for Cancer K. Syrigos and K. Harrington (eds.), Oxford University Press, Oxford, 2003, 29-46.
9. G. Golub and V. Pereyra: Separable nonlinear least squares: the variable projection method and its applications. Inverse Problems 19, 2003, R1-R26.
10. C. Hindorf, S. Chittenden, L. Causer, V.J. Lewington, and H. Macke: Dosimetry for 90Y-DOTATOC therapies in patients with neuroendocrine tumors. Cancer Biol. Radiopharm. 22, 2007, 130-135.
11. IUPAC compendium of chemical terminology. http://goldbook.iupac.org/ B00658.html.
12. E.T. Jaynes:Where do we stand on maximum entropy? In Papers on Probability, Statistics, and Statistical Physics, R.D. Rosenkrantz (ed.), Kluwer Academic, Dordrecht, The Netherlands, 1989, 210-314.
13. A. Mayer, R.J. Francis, S.K. Sharma, B. Tolner, C.J.S. Springer, J. Martin, G.M. Boxer, J. Bell, A.J. Green, J.A. Hartley, C. Cruickshank, J. Wren, K.A. Chester, and R.H.J. Begent: A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anticarcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bisiodo phenol mustard prodrug. Clin. Cancer Res. 12, 2006, 6509-6516.
14. M.G. Stabin and J.A. Siegel: Physical models and dose factors for use in internal dose assessment. Health Phys. 85, 2003, 294.